GENI

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS

GENIL.IS genilac.com.tr
Healthcare · Drug Manufacturers - Specialty & Generic
11.99
+0.05 (+0.42%)
TRY · IS
52-week range
7.11
14.90
Trading at 63% of the 52-week range
Market Cap
53.88B
P/E Ratio
52.17
Forward P/E
0.00
Book Value
2.90
Div. Yield
0.40%
% Institutions
1.64%
% Insiders
72.51%

1 Year

+14.8%

3 Year

+174.5%

10 Year

+1,392.6%
Description

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, trades, imports and exports of all kinds of human medicines and health products. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.

Company Information

▼
Company Name
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
IS
ISIN: TREGENL00024
Currency: TRY
Full Time Employees: 682
Phone: 90 312 219 62 19
Website: genilac.com.tr
Fiscal Year End: December
Description:

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, trades, imports and exports of all kinds of human medicines and health products. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.

Address:

Mustafa Kemal Mahallesi 2119, Çankaya, Turkey, 06520

People

▼

Directors & Officers

Name Title Year Born
Mr. Abidin Gulmus Chairman of the Board & GM NA
Semra Gulmus Founder NA
Yagmur Selin Gulmus Kolay Assistant General Manager of Strategy & Corporate Development 1988
Dr. Deniz Karagulle Global Chief Commercial Officer 1970

Financial Highlights

▼
Market Cap: $53.88B
EBITDA: $2.93B
P/E Ratio: $52.17
Book Value: $2.90
Dividend/Share: $0.05
Dividend Yield: 0.40%
Earnings/Share: $0.23
Profit Margin: 5.21%
Operating Margin: 10.99%
ROA (TTM): 7.99%
ROE (TTM): 10.46%
Revenue (TTM): $22.17B
Revenue/Share (TTM): $4.13
Earnings Growth (YOY): 377.10%
Revenue Growth (YOY): 22.90%

Valuation Metrics

Enterprise Value: $60.51B
Trailing P/E: 52.17
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 4.49B
Shares Float: 298.58M
% Insiders: 72.51%
% Institutions: 1.64%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

▼

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$19.18B
Cost of Goods Sold
adjust
$-15.16B
Gross Profit
subtotal
$4.02B
SG&A
adjust
$-777.53M
R&D
adjust
$-685.71M
Other Operating Expense
adjust
$-15.36B
Operating Income
subtotal
$2.36B
Other / Non-Operating Items
adjust
$-1.54B
Net Income
subtotal
$814.44M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GENIL.IS!